Apellis Pharmaceuticals Inc APLS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/27/21 EDT
65.59UNCH (UNCH)
Volume
11,019
Close
65.59quote price arrow down-1.17 (-1.75%)
Volume
680,759
52 week range
25.49 - 73.00

...

Loading . . .
  • Open66.97
  • Day High67.12
  • Day Low64.85
  • Prev Close65.59
  • 52 Week High73.00
  • 52 Week High Date07/02/21
  • 52 Week Low25.49
  • 52 Week Low Date07/31/20

Key Stats

  • Market Cap5.28B
  • Shares Out80.50M
  • 10 Day Average Volume0.88M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change14.67

KEY STATS

  • Open66.97
  • Day High67.12
  • Day Low64.85
  • Prev Close65.59
  • 52 Week High73.00
  • 52 Week High Date07/02/21
  • 52 Week Low25.49
  • 52 Week Low Date07/31/20
  • Market Cap5.28B
  • Shares Out80.50M
  • 10 Day Average Volume0.88M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change14.67

RATIOS/PROFITABILITY

  • EPS (TTM)-4.65
  • P/E (TTM)-14.10
  • Fwd P/E (NTM)-10.27
  • EBITDA (MRQ)-238.696M
  • ROE (MRQ)-231.58%
  • Revenue (MRQ)250.65M
  • Gross Margin (MRQ)89.75%
  • Net Margin (MRQ)-143.51%
  • Debt To Equity (MRQ)759.54%

EVENTS

  • Earnings Date07/29/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Apellis Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The Company’s lead product candidate is APL-2. APL-2 is Phase III clinical trials developed for the treatment of geographic atrophy (GA) and intermediate...
Gerald Chan Ph.D.
Non-Executive Chairman
Cedric Francois M.D., Ph.D.
President
Nur Nicholson
Chief Operating Officer
Timothy Sullivan
Chief Financial Officer
David Watson
General Counsel
Nicole Perry
Vice President
Address
100 Fifth Avenue
Waltham, MA
02451
United States